Two biologic therapeutic candidates met their primary endpoints in separate Phase III trials: AstraZeneca’s Ultomiris and Argenx’s Vyvgart.
The most obvious risks from COVID-19 are hospitalization and death. But study after study shows the disease comes with an increased risk of a number of health problems, including diabetes.
On the day the public and members of the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee were going to get a look at Pfizer and BioNTech’s COVID-19 vaccine data for children under 5 years old, the companies pulled the Emergency Use Authorization (EUA) submission.
Amidst news of current COVID-19 vaccines proving less effective against infections with Delta and Omicron variants of the disease, researchers are turning toward the development of pan-coronavirus vaccines that would work effectively against multiple variants. Scientists and researchers at the Walter Reed National Military Medical Center (WRNMC) in Maryland have been doing just that over the past two years and announced they are testing the vaccine in humans in a Phase I study.
While wealthier countries have come a long way to boosting their populations with an extra shot of COVID-19 vaccines to protect against Omicron, studies in Israel are evaluating whether a fourth dose of an mRNA vaccine offers additional protection. Although the data is still early, research suggests that it might not.
Surgeons from NYU Langone Health hit a major milestone in transplantation science after successfully attaching a pig’s kidney to a human patient and watching it work for several hours.
Although it’s difficult, when faced with a cancer diagnosis, it’s important to find the best health care facility to receive treatment. Improving the future of cancer tech, this posting looks at some of the most high-tech cancer hospitals in America.
The mRNA vaccine from Pfizer and BioNTech may be less effective than Moderna’s against the Delta variant of the coronavirus, according to two reports posted on medRxiv on Aug. 8 ahead of peer review.
A study found potential in a novel gene therapy method to help children born with a rare genetic and neurodegenerative disorder, AADC deficiency.
GALIEN DIGITAL HEALTH WEBINAR SERIES The Incubators of Innovation: Academic Medical Centers As Digital Health Champions THURSDAY, JUNE 24, 2021 1:00 PM – 2:00 PM ET Register Academic medical center […]
